What is the main business of Biosel?

The main business activity of Biosel focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 1, 2009.

Where is the headquarters located?

The headquarters is located at: ul. Janusza Meissnera 2, 03-982 Warszawa.

Who is on the management board?

The management board consists of: Piotr Roman Suchocki (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.

How much revenue was generated?

In 2022, the company generated total revenue of $19,100.

Is the company profitable?

Yes, in 2022 the company achieved a net profit of $11,380.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to $199 in 2022, representing 91% of all operating expenses.

Bioselsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2009-06-01

Share capital

5 000,00 PLN

Registered address

ul. Janusza Meissnera 2/36, 03-982 Warszawa, Poland

Website

selol.pl

Financials

The financial statement for 2023 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2022.

Results vs industry

Revenue

This companyUSD 19.10kMedianUSD 38.31kAverageUSD 2.31m

Net profit

This companyUSD 11.38kMedianUSD -1.50kAverageUSD -84.98k

Operating costs

This companyUSD 218.33MedianUSD 56.25kAverageUSD 2.29m

Assets

This companyUSD 177.28kMedianUSD 116.77kAverageUSD 2.72m

Industry

Bank accounts

Was a VAT taxpayer from 2010-06-01 to 2023-09-14. Removed from VAT register

Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Piotr Roman Suchocki — President of the Management Board

Manner of representation

The President of the Management Board independently, or two members of the management board jointly.

Ownership

Owner	Shares	Share value	Stake
Piotr Roman Suchocki (76)	96	$1,296.60	96%
Others	4	$54.02	4%

Beneficial owners

Person	Rights
Piotr Roman Suchocki (76)	Shareholder of a limited liability company, 4800.0 PLN

Competitors

Name	Revenue	Website
Explorna Therapeuticssp. z o.o.	$304,662.00	explorna.com
Frontline BiosciencesS.A.	$219,186.29	frontlinebiosciences.com
AI Corelabsp. z o.o.	$128,365.55	aicorelab.com
ModicaP.S.A.	$103,400.72	modica.bio
WPD Pharmaceuticalssp. z o.o.	$90,822.78	wpdpharmaceuticals.com
WPD PharmaceuticalsS.A.	$87,561.70	wpdpharmaceuticals.pl
Stenocoatsp. z o.o.	$36,665.21	stenocoat.com
Platforma Badań Genetycznychsp. z o.o.	$28,558.39	zdrowegeny.pl
Omnisepticasp. z o.o.	$3,475.29	omniseptica.com
Wavex Energysp. z o.o.	$142.33	wavexenergy.com

Change history

Date	Event
2025-03-04	Business suspended
2025-03-02	Business resumed
2023-03-01	Business suspended
2022-11-03	Address change (Świętojerska 16/18, 00-202, Warszawa → Ul. Janusza Meissnera 2/36, 03-982, Warszawa)
2022-08-12	Business resumed

FAQ

Last updated: 2026-04-17